These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18609419

  • 1. Hippocampal remodelling after MDMA neurotoxicity: a single case study.
    Nifosì F, Martinuzzi A, Toffanin T, Costanzo R, Vestri A, Battaglia M, Bertagnoni GE, Lupi A, Amistà P, Carollo C, Perini G.
    World J Biol Psychiatry; 2009; 10(4 Pt 3):961-8. PubMed ID: 18609419
    [Abstract] [Full Text] [Related]

  • 2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
    Casco C, Forcella M, Beretta G, Grieco A, Campana G.
    Addict Biol; 2005 Jun; 10(2):187-95. PubMed ID: 16191672
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.
    Frenzilli G, Ferrucci M, Giorgi FS, Blandini F, Nigro M, Ruggieri S, Murri L, Paparelli A, Fornai F.
    Behav Pharmacol; 2007 Sep; 18(5-6):471-81. PubMed ID: 17762515
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 10. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 11. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):317-23. PubMed ID: 15893163
    [Abstract] [Full Text] [Related]

  • 12. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul 01; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 13. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep 01; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 14. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E, Daumann J.
    J Psychopharmacol; 2006 Mar 01; 20(2):188-93. PubMed ID: 16510477
    [Abstract] [Full Text] [Related]

  • 15. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
    Green AR, O'shea E, Colado MI.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):3-13. PubMed ID: 15464016
    [Abstract] [Full Text] [Related]

  • 16. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL, Shear PK, Corcoran K.
    J Int Neuropsychol Soc; 2005 Oct 01; 11(6):753-65. PubMed ID: 16248911
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
    Garg A, Kapoor S, Goel M, Chopra S, Chopra M, Kapoor A, McCann UD, Behera C.
    Curr Drug Abuse Rev; 2015 Oct 01; 8(1):15-25. PubMed ID: 25731754
    [Abstract] [Full Text] [Related]

  • 19. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan 01; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 20. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
    Montoya AG, Sorrentino R, Lukas SE, Price BH.
    Harv Rev Psychiatry; 2002 Jan 01; 10(4):212-20. PubMed ID: 12119307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.